{"id": "article-301_0", "title": "Propofol Toxicity -- Continuing Education Activity", "content": "Propofol is a phenol derivative administered intravenously that is commonly used for sedation and in general anesthesia. The most common formulation of propofol is a lipophilic emulsion which allows for rapid distribution into the tissues, including across the blood-brain barrier. It is commonly used for sedation in the intensive care unit (ICU) because it has a short duration of action and rapid clearance. It has dose-dependent effects leading to changes in blood pressure and heart rate at higher doses. The initial administration can cause pain at the injection site. Though propofol has a generally favorable profile as a sedative, administration of toxic doses can have harmful effects. Propofol infusion syndrome (PRIS) results from propofol toxicity. This activity reviews the presentation, evaluation, and management of propofol toxicity and stresses the role of an interprofessional team approach to the care of affected patients.", "contents": "Propofol Toxicity -- Continuing Education Activity. Propofol is a phenol derivative administered intravenously that is commonly used for sedation and in general anesthesia. The most common formulation of propofol is a lipophilic emulsion which allows for rapid distribution into the tissues, including across the blood-brain barrier. It is commonly used for sedation in the intensive care unit (ICU) because it has a short duration of action and rapid clearance. It has dose-dependent effects leading to changes in blood pressure and heart rate at higher doses. The initial administration can cause pain at the injection site. Though propofol has a generally favorable profile as a sedative, administration of toxic doses can have harmful effects. Propofol infusion syndrome (PRIS) results from propofol toxicity. This activity reviews the presentation, evaluation, and management of propofol toxicity and stresses the role of an interprofessional team approach to the care of affected patients."}
{"id": "article-301_1", "title": "Propofol Toxicity -- Continuing Education Activity", "content": "Objectives: Describe the evaluation of a patient with propofol toxicity. Review the history and physical exam findings typically present in patients with propofol toxicity. Summarize the treatment options for propofol toxicity. Explain modalities to improve care coordination among interprofessional team members in order to improve outcomes for patients affected by propofol toxicity. Access free multiple choice questions on this topic.", "contents": "Propofol Toxicity -- Continuing Education Activity. Objectives: Describe the evaluation of a patient with propofol toxicity. Review the history and physical exam findings typically present in patients with propofol toxicity. Summarize the treatment options for propofol toxicity. Explain modalities to improve care coordination among interprofessional team members in order to improve outcomes for patients affected by propofol toxicity. Access free multiple choice questions on this topic."}
{"id": "article-301_2", "title": "Propofol Toxicity -- Introduction", "content": "Propofol is a drug commonly used for sedation and the implementation of general anesthesia.\u00a0 It is a phenol derivative given as an intravenous drug.\u00a0 The most common formulation is in a lipophilic emulsion which allows for rapid distribution into the tissues, including across the blood-brain barrier. It is commonly used for sedation in the ICU because it has a short duration of action and rapid clearance.\u00a0 It has dose-dependent effects leading to changes in blood pressure and heart rate at higher doses. \u00a0The initial administration can cause pain at the injection site. Though propofol has a generally favorable profile as a sedative, administering toxic doses can harm a patient\u2019s overall condition.\u00a0 Propofol infusion syndrome (PRIS) is the manifestation of propofol toxicity. [1]", "contents": "Propofol Toxicity -- Introduction. Propofol is a drug commonly used for sedation and the implementation of general anesthesia.\u00a0 It is a phenol derivative given as an intravenous drug.\u00a0 The most common formulation is in a lipophilic emulsion which allows for rapid distribution into the tissues, including across the blood-brain barrier. It is commonly used for sedation in the ICU because it has a short duration of action and rapid clearance.\u00a0 It has dose-dependent effects leading to changes in blood pressure and heart rate at higher doses. \u00a0The initial administration can cause pain at the injection site. Though propofol has a generally favorable profile as a sedative, administering toxic doses can harm a patient\u2019s overall condition.\u00a0 Propofol infusion syndrome (PRIS) is the manifestation of propofol toxicity. [1]"}
{"id": "article-301_3", "title": "Propofol Toxicity -- Etiology", "content": "Propofol infusion syndrome usually presents in patients who have been administered propofol for an extended time at high doses.\u00a0 Based on published case reports, the odds of developing PRIS increase when propofol is administered for over 48 hours or at a rate of around 4mg/kg/hr (67mcg/kg/minute). [2]", "contents": "Propofol Toxicity -- Etiology. Propofol infusion syndrome usually presents in patients who have been administered propofol for an extended time at high doses.\u00a0 Based on published case reports, the odds of developing PRIS increase when propofol is administered for over 48 hours or at a rate of around 4mg/kg/hr (67mcg/kg/minute). [2]"}
{"id": "article-301_4", "title": "Propofol Toxicity -- Etiology", "content": "Risk factors include severe illnesses such as sepsis, cerebral injury, airway infection, and poor oxygen perfusion. Other possible considerations that may play a role in PRIS are low carbohydrate levels, use of glucocorticoids, subclinical mitochondrial disease, and carnitine deficiency. [2]", "contents": "Propofol Toxicity -- Etiology. Risk factors include severe illnesses such as sepsis, cerebral injury, airway infection, and poor oxygen perfusion. Other possible considerations that may play a role in PRIS are low carbohydrate levels, use of glucocorticoids, subclinical mitochondrial disease, and carnitine deficiency. [2]"}
{"id": "article-301_5", "title": "Propofol Toxicity -- Epidemiology", "content": "Pain on propofol injection usually occurs in younger patients from 20 to 40 years old. It is also more common in females and in a peripheral IV site. [3]", "contents": "Propofol Toxicity -- Epidemiology. Pain on propofol injection usually occurs in younger patients from 20 to 40 years old. It is also more common in females and in a peripheral IV site. [3]"}
{"id": "article-301_6", "title": "Propofol Toxicity -- Epidemiology", "content": "When propofol infusion syndrome was first identified, the typical presentation was a pediatric patient in the ICU under sedation with high doses of propofol.\u00a0 With the reporting of more cases, the average age has increased to around 58 years old. \u00a0Overall, the incidence of PRIS is 1.1% in those who receive propofol \u00ad\u00ad infusions.\u00a0 PRIS more commonly occurs in males than in females. Studies have varied the estimated mortality rate from 18 to 32%. [4] [2] [5]", "contents": "Propofol Toxicity -- Epidemiology. When propofol infusion syndrome was first identified, the typical presentation was a pediatric patient in the ICU under sedation with high doses of propofol.\u00a0 With the reporting of more cases, the average age has increased to around 58 years old. \u00a0Overall, the incidence of PRIS is 1.1% in those who receive propofol \u00ad\u00ad infusions.\u00a0 PRIS more commonly occurs in males than in females. Studies have varied the estimated mortality rate from 18 to 32%. [4] [2] [5]"}
{"id": "article-301_7", "title": "Propofol Toxicity -- Pathophysiology", "content": "Initial pain from propofol injection occurs due to endothelial irritation.\u00a0 Studies show that propofol initiates a cascade that leads to neurogenic inflammation in the spinal dorsal horn, which can cause injection pain to last 10 to 20 seconds. [3]", "contents": "Propofol Toxicity -- Pathophysiology. Initial pain from propofol injection occurs due to endothelial irritation.\u00a0 Studies show that propofol initiates a cascade that leads to neurogenic inflammation in the spinal dorsal horn, which can cause injection pain to last 10 to 20 seconds. [3]"}
{"id": "article-301_8", "title": "Propofol Toxicity -- Pathophysiology", "content": "When propofol reaches a toxic level, it uncouples oxidative phosphorylation in the mitochondrial electron transport chain. \u00a0Propofol also inhibits carnitine palmitoyltransferase, which is a part of fatty acid metabolism. Fatty acid accumulation can lead to arrhythmias and poor energy availability. \u00a0\u00a0An imbalance of energy supply and demand can further lead to organ dysfunction throughout the body. [6] [4] [7]", "contents": "Propofol Toxicity -- Pathophysiology. When propofol reaches a toxic level, it uncouples oxidative phosphorylation in the mitochondrial electron transport chain. \u00a0Propofol also inhibits carnitine palmitoyltransferase, which is a part of fatty acid metabolism. Fatty acid accumulation can lead to arrhythmias and poor energy availability. \u00a0\u00a0An imbalance of energy supply and demand can further lead to organ dysfunction throughout the body. [6] [4] [7]"}
{"id": "article-301_9", "title": "Propofol Toxicity -- Histopathology", "content": "Studies on human skeletal muscles show that higher doses of propofol (10mcg/mL) can lead to microscopic changes affecting cell survival.\u00a0 Mitochondrial membranes were affected, which caused a decrease in electron transport chain capacity.\u00a0 Furthermore, propofol inhibited fatty acid oxidation, which may contribute to the lost spare electron transfer chain capacity. [6]", "contents": "Propofol Toxicity -- Histopathology. Studies on human skeletal muscles show that higher doses of propofol (10mcg/mL) can lead to microscopic changes affecting cell survival.\u00a0 Mitochondrial membranes were affected, which caused a decrease in electron transport chain capacity.\u00a0 Furthermore, propofol inhibited fatty acid oxidation, which may contribute to the lost spare electron transfer chain capacity. [6]"}
{"id": "article-301_10", "title": "Propofol Toxicity -- Histopathology", "content": "Biopsies of skeletal muscle from patients with known PRIS reveal disorganized myofibrils and sarcomeres, as well as necrotic reactions.\u00a0 Kidneys had myoglobin casts with acute tubular necrosis.\u00a0 Cardiac histology showed myofibril degeneration with acute inflammation. [8]", "contents": "Propofol Toxicity -- Histopathology. Biopsies of skeletal muscle from patients with known PRIS reveal disorganized myofibrils and sarcomeres, as well as necrotic reactions.\u00a0 Kidneys had myoglobin casts with acute tubular necrosis.\u00a0 Cardiac histology showed myofibril degeneration with acute inflammation. [8]"}
{"id": "article-301_11", "title": "Propofol Toxicity -- Histopathology", "content": "In animal models, histologic exams show a range of organ dysfunction.\u00a0 The liver revealed focal liver cell necrosis and steatosis.\u00a0 There was evidence of interstitial pneumonia and pulmonary edema in the lungs.\u00a0 Skeletal muscle biopsies had signs of muscle necrosis and rhabdomyolysis.\u00a0 Other findings included myocarditis, loss of urinary bladder epithelium, and cholangitis. [7]", "contents": "Propofol Toxicity -- Histopathology. In animal models, histologic exams show a range of organ dysfunction.\u00a0 The liver revealed focal liver cell necrosis and steatosis.\u00a0 There was evidence of interstitial pneumonia and pulmonary edema in the lungs.\u00a0 Skeletal muscle biopsies had signs of muscle necrosis and rhabdomyolysis.\u00a0 Other findings included myocarditis, loss of urinary bladder epithelium, and cholangitis. [7]"}
{"id": "article-301_12", "title": "Propofol Toxicity -- History and Physical", "content": "Because propofol administration is intravenous, injection pain is a common side effect of its administration. \u00a0Patients often complain of burning upon injection, lasting up to 20 seconds. [3]", "contents": "Propofol Toxicity -- History and Physical. Because propofol administration is intravenous, injection pain is a common side effect of its administration. \u00a0Patients often complain of burning upon injection, lasting up to 20 seconds. [3]"}
{"id": "article-301_13", "title": "Propofol Toxicity -- History and Physical", "content": "If propofol infusion syndrome is suspected, the patient will present with metabolic acidosis with elevated lactic acid.\u00a0 Cardiac derangements may include hypotension, bradycardia, right bundle branch block, cardiac arrhythmias, and asystole.\u00a0 ECG may show toxicity with a Brugada-like pattern and a convex ST-elevation in the suitable precordial leads. Musculoskeletal injury can occur in the form of rhabdomyolysis and myopathy. Other signs may reflect renal and hepatic abnormalities, such as oliguria or hepatomegaly, respectively.\u00a0 Urine has also been noted to have a red or green appearance. [4] [7]", "contents": "Propofol Toxicity -- History and Physical. If propofol infusion syndrome is suspected, the patient will present with metabolic acidosis with elevated lactic acid.\u00a0 Cardiac derangements may include hypotension, bradycardia, right bundle branch block, cardiac arrhythmias, and asystole.\u00a0 ECG may show toxicity with a Brugada-like pattern and a convex ST-elevation in the suitable precordial leads. Musculoskeletal injury can occur in the form of rhabdomyolysis and myopathy. Other signs may reflect renal and hepatic abnormalities, such as oliguria or hepatomegaly, respectively.\u00a0 Urine has also been noted to have a red or green appearance. [4] [7]"}
{"id": "article-301_14", "title": "Propofol Toxicity -- Evaluation", "content": "Clinical evaluation of the patient is essential to look for signs of organ dysfunction, especially if the patient cannot vocalize any discomfort due to the propofol sedation \u2014 signs such as dark urine from rhabdomyolysis or hepatomegaly.", "contents": "Propofol Toxicity -- Evaluation. Clinical evaluation of the patient is essential to look for signs of organ dysfunction, especially if the patient cannot vocalize any discomfort due to the propofol sedation \u2014 signs such as dark urine from rhabdomyolysis or hepatomegaly."}
{"id": "article-301_15", "title": "Propofol Toxicity -- Evaluation", "content": "Monitoring lab values regularly upon initiating and during propofol infusion will be essential to ascertain any early signs of PRIS.\u00a0 Results may reflect multi-organ system dysfunction.\u00a0 Serum lab values can reveal a high anion gap metabolic acidosis, lactic acidosis, and lipemic plasma.\u00a0 Additionally, there may be elevated serum creatine kinase, serum myoglobin, serum urea, serum potassium, and liver enzymes.\u00a0 Hypertriglyceridemia is not unexpected due to the lipemic nature of the medication, which can lead to pancreatitis. [2]", "contents": "Propofol Toxicity -- Evaluation. Monitoring lab values regularly upon initiating and during propofol infusion will be essential to ascertain any early signs of PRIS.\u00a0 Results may reflect multi-organ system dysfunction.\u00a0 Serum lab values can reveal a high anion gap metabolic acidosis, lactic acidosis, and lipemic plasma.\u00a0 Additionally, there may be elevated serum creatine kinase, serum myoglobin, serum urea, serum potassium, and liver enzymes.\u00a0 Hypertriglyceridemia is not unexpected due to the lipemic nature of the medication, which can lead to pancreatitis. [2]"}
{"id": "article-301_16", "title": "Propofol Toxicity -- Evaluation", "content": "It is critical to monitor closely for any cardiac abnormalities.\u00a0 Any hint of arrhythmias may be an early sign of toxicity, and further tests must occur. \u00a0Patients should be on telemetry, and serial EKGs are a consideration. Bradycardia is often the first sign of heart irregularities.", "contents": "Propofol Toxicity -- Evaluation. It is critical to monitor closely for any cardiac abnormalities.\u00a0 Any hint of arrhythmias may be an early sign of toxicity, and further tests must occur. \u00a0Patients should be on telemetry, and serial EKGs are a consideration. Bradycardia is often the first sign of heart irregularities."}
{"id": "article-301_17", "title": "Propofol Toxicity -- Treatment / Management", "content": "Lidocaine has been used to reduce propofol injection pain.\u00a0 It is usable either mixed with the propofol or before propofol administration.\u00a0 Either technique has demonstrated effectiveness. [9]", "contents": "Propofol Toxicity -- Treatment / Management. Lidocaine has been used to reduce propofol injection pain.\u00a0 It is usable either mixed with the propofol or before propofol administration.\u00a0 Either technique has demonstrated effectiveness. [9]"}
{"id": "article-301_18", "title": "Propofol Toxicity -- Treatment / Management", "content": "Due to the severe progression of PRIS, clinicians must have a high degree of suspicion of the disease to treat it properly.\u00a0 The first step to prevent worsening conditions is to discontinue the propofol infusion.\u00a0 If the patient still requires sedation due to other factors, another class of sedative should be substituted.\u00a0 The patient should then be hemodynamically stabilized.\u00a0 In severe cases, patients may require advanced cardiorespiratory support such as extracorporeal membranous oxygenation (ECMO).\u00a0 Severe bradycardia may require cardiac pacing.\u00a0 Propofol can inhibit calcium channel blockers, thus making the heart resistant to catecholamine interventions. [2]", "contents": "Propofol Toxicity -- Treatment / Management. Due to the severe progression of PRIS, clinicians must have a high degree of suspicion of the disease to treat it properly.\u00a0 The first step to prevent worsening conditions is to discontinue the propofol infusion.\u00a0 If the patient still requires sedation due to other factors, another class of sedative should be substituted.\u00a0 The patient should then be hemodynamically stabilized.\u00a0 In severe cases, patients may require advanced cardiorespiratory support such as extracorporeal membranous oxygenation (ECMO).\u00a0 Severe bradycardia may require cardiac pacing.\u00a0 Propofol can inhibit calcium channel blockers, thus making the heart resistant to catecholamine interventions. [2]"}
{"id": "article-301_19", "title": "Propofol Toxicity -- Treatment / Management", "content": "The following steps to treat PRIS involve resolving the derangements caused by propofol.\u00a0 Any electrolyte abnormalities need to be either replaced or reduced.\u00a0 Hyperkalemia is treatable with calcium, insulin, beta2 agonists, or K-binders.\u00a0 Metabolic acidosis often needs to be normalized with continuous renal replacement therapy (CRRT).\u00a0 CRRT, therapeutic plasma exchange, hemodialysis, and hemofiltration are options that may help reduce serum levels of propofol, propofol metabolites, and elevated electrolytes.\u00a0 Additionally, carbohydrate substitution has been shown to support fat metabolism. [10] [11]", "contents": "Propofol Toxicity -- Treatment / Management. The following steps to treat PRIS involve resolving the derangements caused by propofol.\u00a0 Any electrolyte abnormalities need to be either replaced or reduced.\u00a0 Hyperkalemia is treatable with calcium, insulin, beta2 agonists, or K-binders.\u00a0 Metabolic acidosis often needs to be normalized with continuous renal replacement therapy (CRRT).\u00a0 CRRT, therapeutic plasma exchange, hemodialysis, and hemofiltration are options that may help reduce serum levels of propofol, propofol metabolites, and elevated electrolytes.\u00a0 Additionally, carbohydrate substitution has been shown to support fat metabolism. [10] [11]"}
{"id": "article-301_20", "title": "Propofol Toxicity -- Differential Diagnosis", "content": "Due to the many manifestations of PRIS, clinicians need to discern whether the signs and symptoms presented by a patient are due to propofol or another pathophysiologic mechanism. If propofol infusions are overlooked, the patient\u2019s condition may be considered to result from other severe illnesses such as shock, sepsis, or renal disease.\u00a0 Other possibilities are congenital problems (i.e., Brugada Syndrome) or other medications that may be concomitantly given. If propofol is being administered, then PRIS must remain high on the differential. [12]", "contents": "Propofol Toxicity -- Differential Diagnosis. Due to the many manifestations of PRIS, clinicians need to discern whether the signs and symptoms presented by a patient are due to propofol or another pathophysiologic mechanism. If propofol infusions are overlooked, the patient\u2019s condition may be considered to result from other severe illnesses such as shock, sepsis, or renal disease.\u00a0 Other possibilities are congenital problems (i.e., Brugada Syndrome) or other medications that may be concomitantly given. If propofol is being administered, then PRIS must remain high on the differential. [12]"}
{"id": "article-301_21", "title": "Propofol Toxicity -- Prognosis", "content": "PRIS has a poor prognosis, especially if not identified early. As stated before, the mortality rate varies but is about 18 to 32%.\u00a0 Patients have an improved chance of survival if clinicians are aware of the risks and the early signs of the syndrome.", "contents": "Propofol Toxicity -- Prognosis. PRIS has a poor prognosis, especially if not identified early. As stated before, the mortality rate varies but is about 18 to 32%.\u00a0 Patients have an improved chance of survival if clinicians are aware of the risks and the early signs of the syndrome."}
{"id": "article-301_22", "title": "Propofol Toxicity -- Complications", "content": "The primary concern with propofol toxicity is the development of fatal conditions.\u00a0 Hypertriglyceridemia can lead to pancreatitis.\u00a0 Metabolic acidosis can develop, leading to other derangements.\u00a0 Cardiac failure and rhabdomyolysis are significant concerns for propofol toxicity.\u00a0 If PRIS continues without any timely intervention, the condition can be fatal. \u00a0Some complications correlate with complex multimodal treatment options.", "contents": "Propofol Toxicity -- Complications. The primary concern with propofol toxicity is the development of fatal conditions.\u00a0 Hypertriglyceridemia can lead to pancreatitis.\u00a0 Metabolic acidosis can develop, leading to other derangements.\u00a0 Cardiac failure and rhabdomyolysis are significant concerns for propofol toxicity.\u00a0 If PRIS continues without any timely intervention, the condition can be fatal. \u00a0Some complications correlate with complex multimodal treatment options."}
{"id": "article-301_23", "title": "Propofol Toxicity -- Deterrence and Patient Education", "content": "A complete patient history is necessary before starting a propofol infusion.\u00a0 Patients should be encouraged to share any pertinent information that may deter using propofol as a sedative agent.\u00a0\u00a0 Any previous reactions with propofol or a known mitochondrial disease could clue clinicians into a high risk of adverse effects. \u00a0If there is a concern that high doses of propofol would be required or a patient is at risk of toxicity, another sedative should be considered.", "contents": "Propofol Toxicity -- Deterrence and Patient Education. A complete patient history is necessary before starting a propofol infusion.\u00a0 Patients should be encouraged to share any pertinent information that may deter using propofol as a sedative agent.\u00a0\u00a0 Any previous reactions with propofol or a known mitochondrial disease could clue clinicians into a high risk of adverse effects. \u00a0If there is a concern that high doses of propofol would be required or a patient is at risk of toxicity, another sedative should be considered."}
{"id": "article-301_24", "title": "Propofol Toxicity -- Enhancing Healthcare Team Outcomes", "content": "Propofol toxicity is primarily a healthcare professional\u2019s responsibility to recognize and manage.\u00a0 First and foremost, the patient must be an appropriate candidate for propofol administration.\u00a0 Second, education for the clinical team on the proper use of propofol is a requirement; this includes knowing the limits of safe infusion rates.\u00a0 Pharmacists can check that the correct medication formulation and concentration are ready for use.\u00a0 The propofol administration should be with pumps with defined maximum infusion limits.\u00a0 Nursing staff should never let rates exceed 4mg/kg/min.\u00a0 Regular physical examinations and workups of the patient\u2019s condition should be monitored.\u00a0 Close supervision of the patient is necessary.\u00a0 Dietitians may be helpful to the team in safely increasing carbohydrate load to help prevent propofol toxicity. If PRIS is suspected, the team must take quick action to stop the propofol\u00a0infusion and treat it accordingly. All these interprofessional personnel working together as a coordinated healthcare team can best ensure the safe use of propofol for procedures, as well as reacting to PRIS if it does begin to manifest. [Level 5]", "contents": "Propofol Toxicity -- Enhancing Healthcare Team Outcomes. Propofol toxicity is primarily a healthcare professional\u2019s responsibility to recognize and manage.\u00a0 First and foremost, the patient must be an appropriate candidate for propofol administration.\u00a0 Second, education for the clinical team on the proper use of propofol is a requirement; this includes knowing the limits of safe infusion rates.\u00a0 Pharmacists can check that the correct medication formulation and concentration are ready for use.\u00a0 The propofol administration should be with pumps with defined maximum infusion limits.\u00a0 Nursing staff should never let rates exceed 4mg/kg/min.\u00a0 Regular physical examinations and workups of the patient\u2019s condition should be monitored.\u00a0 Close supervision of the patient is necessary.\u00a0 Dietitians may be helpful to the team in safely increasing carbohydrate load to help prevent propofol toxicity. If PRIS is suspected, the team must take quick action to stop the propofol\u00a0infusion and treat it accordingly. All these interprofessional personnel working together as a coordinated healthcare team can best ensure the safe use of propofol for procedures, as well as reacting to PRIS if it does begin to manifest. [Level 5]"}
{"id": "article-301_25", "title": "Propofol Toxicity -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Propofol Toxicity -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}